|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to New York Times Health News Archives
New York Times Health News: 10-10-2004
The government has spent $2.3 million in the past 4 years to study something that critics say has nothing to do with science.
A team from the Food and Drug Administration met British regulators about their decision to quarantine nearly half the United States' supply of flu vaccine.
A Superior Court jury found that the Botox injections administered by a Beverly Hills dermatologist did not cause the ailments that a patient complained about.
Democratic lawmakers introduced legislation that would require makers of drugs and medical devices to register clinical trials of their products in a public database.
The flu season is not here yet, but the shortage has prompted an uncertain triage of prevention.
|
|
